- Report
- October 2024
- 198 Pages
Global
From €3360EUR$3,545USD£2,807GBP
€3733EUR$3,939USD£3,119GBP
- Report
- July 2024
- 175 Pages
Global
From €4739EUR$5,000USD£3,959GBP
- Report
- October 2024
- 182 Pages
Global
From €3360EUR$3,545USD£2,807GBP
€3733EUR$3,939USD£3,119GBP
- Report
- August 2024
- 182 Pages
Global
From €4218EUR$4,450USD£3,524GBP
- Report
- June 2024
- 185 Pages
Global
From €4265EUR$4,500USD£3,563GBP
- Report
- July 2019
- 165 Pages
Global
From €4692EUR$4,950USD£3,920GBP
- Report
- January 2024
- 150 Pages
Global
From €4597EUR$4,850USD£3,840GBP
- Report
- November 2023
- 182 Pages
Global
From €3411EUR$3,599USD£2,850GBP
- Report
- April 2023
- 78 Pages
Global
From €3500EUR$3,956USD£3,026GBP
Salinomycin is an antibiotic used to treat a variety of bacterial infections. It is a polyether ionophore, a type of antibiotic that works by disrupting the cell membrane of bacteria. Salinomycin is used to treat infections caused by Gram-positive bacteria, such as Staphylococcus aureus and Streptococcus pneumoniae. It is also used to treat infections caused by Gram-negative bacteria, such as Escherichia coli and Pseudomonas aeruginosa. Salinomycin is also used to treat fungal infections, such as Candida albicans.
Salinomycin is available in both oral and injectable forms. It is usually prescribed as a single dose or as a course of treatment. The most common side effects of salinomycin include nausea, vomiting, diarrhea, and abdominal pain.
Salinomycin is used in combination with other antibiotics to treat a variety of infections. It is also used in combination with other drugs to treat cancer.
The salinomycin market is highly competitive, with many companies offering a variety of products. Some of the major players in the market include Pfizer, Merck, Novartis, Sanofi, and GlaxoSmithKline. Show Less Read more